NSE - Delayed Quote INR
Nectar Lifesciences Limited (NECLIFE.NS)
22.83
-1.07
(-4.48%)
At close: April 25 at 3:29:47 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
1,398,799
2,246,860
1,336,510
950,050
213,790
Investing Cash Flow
-479,829
-170,250
517,040
166,440
-286,240
Financing Cash Flow
-847,803
-2,054,350
-1,855,830
-1,193,800
114,900
End Cash Position
278,778
198,060
175,800
178,080
255,390
Capital Expenditure
-495,696
-294,150
-300,600
-249,700
-312,410
Free Cash Flow
903,103
1,952,710
1,035,910
700,350
-98,620
3/31/2021 - 7/18/2005
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SMRUTHIORG.BO Smruthi Organics Limited
116.00
-3.29%
ZYDUSLIFE.NS Zydus Lifesciences Limited
859.65
-2.34%
CIPLA.NS Cipla Limited
1,525.90
-1.66%
SUNPHARMA.NS Sun Pharmaceutical Industries Limited
1,787.40
-0.91%
LAURUSLABS.NS Laurus Labs Limited
625.65
-3.08%
CRON Cronos Group Inc.
1.8000
-2.70%
CURLF Curaleaf Holdings, Inc.
0.9540
-2.65%
TLRY Tilray Brands, Inc.
0.4871
-1.06%